BlackBerry Ltd (NASDAQ:BBRY) (TSE:BB) takes pride in securing U.S. President Barack Obama’s mobile communications. Devices made by the Canadian company meet the high-security needs of the government agencies. Sources close to the matter told Will Connors of The Wall Street Journal that the White House is currently conducting security tests for smartphones from Samsung Electronics Co., Ltd. (LON:BC94) (KRX:005930) and LG Electronics Inc. (KRX:066570) (OTCMKTS:LGEAF) for internal use. This has threatened the most high profile stronghold of the ailing Canadian company. BlackBerry Ltd (NASDAQ:BBRY) shares after opening at $9.66 moved to $9.67 on last trade day and at the end of the day closed at $9.18. Company price to sales ratio in past twelve months was calculated as 0.38 and price to cash ratio as 1.76. BlackBerry Ltd (NASDAQ:BBRY) showed a negative weekly performance of -1.40%.
Shares of Broadcom Corp. (NASDAQ:BRCM) were the target of unusually large options trading activity on Friday. Stock investors acquired 20,184 call options on the stock, American Banking News reports. This represents an increase of approximately 254% compared to the average daily volume of 5,698 call options. Broadcom Corporation (NASDAQ:BRCM) shares fell -0.19% in last trading session and ended the day on $31.28. BRCM return on equity ratio is recorded as 5.30% and its return on assets is 3.70%. Broadcom Corporation (NASDAQ:BRCM) yearly performance is -7.86%.
Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Akshay Vaishnaw sold 32,769 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $73.95, for a total value of $2,423,267.55. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares moved down -4.49% in last trading session and was closed at $69.99, while trading in range of $68.02-$73.44. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) year to date performance is 8.85%.
Stifel Nicolaus began coverage on shares of ZELTIQ Aesthetics (NASDAQ:ZLTQ) in a research note issued on Wednesday,TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $28.00 price target on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 51.93% from the stock’s previous close. Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) weekly performance is 2.66%. On last trading day company shares ended up $18.52.Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) distance from 50-day simple moving average is -5.84%. Analysts mean target price for the company is $24.71.
Leave a Reply